Teva North America Recall: ARGATROBAN Injection in 0.9% Sodium Chloride 250 mg/250 mL (1 m
Teva North America Recall: ARGATROBAN Injection in 0.9% Sodium Chloride 250 mg/250 mL (1 m is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Teva North America; Product: ARGATROBAN Injection in 0.9% Sodium Chloride 250 mg/250 mL (1 mg/mL) , Rx Only, Manufactured in Hungary for TEVA PHARM
| Recalling firm | Teva North America |
|---|---|
| Product | ARGATROBAN Injection in 0.9% Sodium Chloride 250 mg/250 mL (1 mg/mL) , Rx Only, Manufactured in Hungary for TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC# 0703-0020-31 (Single Use Bag), NDC # 0703-0020-32 (5 Single Use Bags in One Carton). |
| Reason for recall | CGMP Deviations |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Terminated |
| Distribution | Nationwide and Puerto Rico |
| Recall initiated | 20160617 |
| Recall number | D-1494-2016 |
| Category | drug |
| State | PA |
| Country | United States |
$29/mo
Try RecallGuard →